Cremer's Y-Base Blend Targets Fermentation Startups with Scalable Yeast Solution

German agrifood company Cremer Group launched a high-performing yeast blend designed to simplify fermentation for food startups, potentially lowering production costs for affordable food.

Cremer Group, a Hamburg-based German agrifood company, launched Y-Base Blend—a trace element blend for yeast fermentation processes—specifically for food startups producing functional ingredients. Developed after analyzing 50,000 trace element combinations, the blend was selected from 3,300 experiments across different yeast strains and 9 high-performing formulations tested at microlitre scale. It maintains identical composition from lab (1kg) to industrial (tonnes) production and outperformed Cremer’s in-house blends in over 50% of early-access trials with select partners. The blend is validated through bioreactor testing in customer processes and supports Cremer’s existing 1,300-tonne annual production of alternative proteins.

The blend’s scalability and precision—engineered to work across production scales without reconfiguration—address a key bottleneck for fermentation startups. By simplifying trace element management, it reduces trial-and-error costs while maintaining performance consistency. This directly lowers the barrier to entry for startups developing affordable, nutrient-dense fermented foods and animal feed.

For SUSTENANCE, this means fermentation-based food production could become more cost-effective for startups targeting food security. Lower production costs for functional ingredients might enable cheaper, more accessible fermented foods—like plant-based proteins or probiotic-rich staples—without compromising quality. The blend’s focus on scalability also supports rapid deployment in regions where affordable protein access is critical.

What to watch: Full-scale validation in real-world production settings. Current performance claims are limited to early-access trials with select partners, not industrial deployment. Cremer’s partnership with Munich’s Differential Bio (TUM spinoff) will likely drive next-phase testing, but widespread adoption depends on overcoming the gap between lab-scale results and large-scale food systems.

Source: Green Queen